Quality assurance and characterization of narrowband ultraviolet B devices for use at home: lessons from the HI-Light Vitiligo Trial

Br J Dermatol. 2021 May;184(5):954-955. doi: 10.1111/bjd.19630. Epub 2020 Nov 29.

Authors

A Rogers¹, P Akram¹, J M Batchelor², J Crutchley¹, M Grocki¹, R H Haines³, G Meakin³, K O'Dowd¹, J Ravenscroft⁴, K S Thomas²

Affiliations

¹ Department of Medical Physics and Clinical Engineering, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, UK.
² Centre of Evidence Based Dermatology, King's Meadow Campus, Lenton Lane, Nottingham, NG7 2NR, UK.
³ Nottingham Clinical Trials Unit, University of Nottingham, Queen's Medical Centre, Nottingham, NG7 2UH, UK.
⁴ Department of Dermatology, Nottingham University Hospitals NHS Trust, Nottingham, NG7 2UH, UK.

No abstract available

Publication types

Letter

MeSH terms

Humans
Hypopigmentation*
Treatment Outcome
Ultraviolet Therapy*
Vitiligo* / radiotherapy

Grants and funding